Itay&Beyond
Itay&Beyond is a biotech company revolutionizing neurological and psychiatric drug development. Their platform integrates patient-derived brain organoids with AI analysis to predict drug efficacy, overcoming the limitations of traditional animal models. The system provides functional readouts from brain organoids, enabling accurate drug efficacy prediction. Itay&Beyond's approach aims to accelerate the discovery of new treatments for neurological and psychiatric disorders, with a focus on improving patient outcomes. The company was founded by Dr. Nisim Perets, Mr. Shmulik Bezalel, and Mr. Boaz Goldman.
Itay&Beyond
Itay&Beyond is a biotech company revolutionizing neurological and psychiatric drug development. Their platform integrates patient-derived brain organoids with AI analysis to predict drug efficacy, overcoming the limitations of traditional animal models. The system provides functional readouts from brain organoids, enabling accurate drug efficacy prediction. Itay&Beyond's approach aims to accelerate the discovery of new treatments for neurological and psychiatric disorders, with a focus on improving patient outcomes. The company was founded by Dr. Nisim Perets, Mr. Shmulik Bezalel, and Mr. Boaz Goldman.